Andrea Kießling

2.0k citations
39 papers · 1.4k indexed · h-index 20
Topics
Immunotherapy and Immune Responses (12 papers)Biosimilars and Bioanalytical Methods (10 papers)CAR-T cell therapy research (9 papers)

In The Last Decade

Andrea Kießling

35 papers receiving 1.3k citations

Peers

Andrea Kießling
Comparison fields: 5 of 88
  • Immunology 657
  • Molecular Biology 591
  • Oncology 434
  • Radiology, Nuclear Medicine and Imaging 284
  • Pulmonary and Respiratory Medicine 160
Replace Eric S. Day with:
Eric S. Day United States
Shengzhang Lin China
Juliette Humeau France
Jiandong Zhao China
Zhaojin Yu China
Nameer B. Kirma United States
Steven Grant United States
Sinisa Dovat United States
Makoto Katsumata United States
Rémy Castellano France
Andrea Kießling relative to Eric S. Day United States Eric S. Day's profile →
Citations per field
00.5×9.4×
Eric S. Day · 1×
Citations per year

Countries citing papers authored by Andrea Kießling

Since Specialization
Citations

This map shows the geographic impact of Andrea Kießling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kießling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kießling more than expected).

Fields of papers citing papers by Andrea Kießling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Kießling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kießling. The network helps show where Andrea Kießling may publish in the future.

Co-authorship network of co-authors of Andrea Kießling

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kießling. A scholar is included among the top collaborators of Andrea Kießling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kießling. Andrea Kießling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 39
4 6
5 20
6 13
7 64
8 35
9 163
10 71
11 54
12 44
13 68
14 112
15 14
16 5
17 17
18 21
19 45
20 61

About Andrea Kießling

Andrea Kießling is a scholar working on Immunology, Oncology and Small Animals, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Biosimilars and Bioanalytical Methods (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Immunology (657 citations), Sensory Systems (101 citations) and Oncology (434 citations). Andrea Kießling has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Bernd Weigle, Marc Schmitz, E. Peter Rieber, Michael Bachmann, Achim Temme, Michael A. Rieger, Manfred P. Wirth, S. Füssel, Frank R. Brennan and Sebastian Spindeldreher. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026